title: Severe adverse reaction to high dose epirubicin and cyclophosphamide for poor prognosis breast cancer.
authors.forename: C J
authors.initials: CJ
authors.lastname: Turtle
authors.forename: D M
authors.initials: DM
authors.lastname: Keefe
authors.forename: D
authors.initials: D
authors.lastname: Bell
authors.forename: H
authors.initials: H
authors.lastname: Wheeler
authors.forename: D D
authors.initials: DD
authors.lastname: Ma
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D004487:Edema / Q000139:chemically induced; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects*; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D000860:Hypoxia / Q000139:chemically induced; D008875:Middle Aged; D011379:Prognosis
chemical_list: D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D003520:Cyclophosphamide